North Crest Asset Manangement, LLC Bristol Myers Squibb CO Transaction History
North Crest Asset Manangement, LLC
- $3.22 Billion
- Q4 2024
A detailed history of North Crest Asset Manangement, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 114,959 shares of BMY stock, worth $7.01 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
114,959
Previous 154,332
25.51%
Holding current value
$7.01 Million
Previous $8.73 Million
25.51%
% of portfolio
0.2%
Previous 0.27%
Shares
14 transactions
Others Institutions Holding BMY
# of Institutions
2,769Shares Held
1.56BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.68 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.86 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.8 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.68 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $130B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...